Featured Research

from universities, journals, and other organizations

Hybrid Antibody Created At National Jewish Medical And Research Center 'Turns Off' CD4 T Cells Responsible For Organ Transplant Rejection

Date:
February 26, 1998
Source:
National Jewish Medical And Research Center
Summary:
Organ transplant rejection caused by CD4 T cells could be stopped in the future using a new hybrid antibody developed at National Jewish Medical and Research Center.

DENVER--Organ transplant rejection caused by CD4 T cells could be stopped in the future using a new hybrid antibody developed at National Jewish Medical and Research Center.

Related Articles


In the March issue of Nature Biotechnology, National Jewish researcher Uwe Staerz, M.D., Ph.D., describes a promising new way to "turn off" the CD4 T cell's attack on a transplanted organ. In 1996, Dr. Staerz described how to control CD8 T cells, which also play a major role in organ transplant rejection.

Dr. Staerz estimates clinical trials with the hybrid antibody could take place in approximately two years.

The hybrid antibody developed by Dr. Staerz and Yan Qi, M.D., of National Jewish, selectively "turns off" only the CD4 T cells that attack a transplanted organ. The rest of the body's defenses would be unaffected by the hybrid antibody, allowing the immune system to combat other illnesses. "The T cell sees the transplanted cell, but can't be activated against it," Dr. Staerz explains. "Any other immune response, such as the body defending itself against infections, will go on at the same time without being affected."

Current anti-rejection drugs stop organ rejection and completely suppress the body's immune system, sometimes allowing development of pneumonia, cancer, or other diseases or illnesses.

"Everybody who gets an organ transplant gets sick to a certain extent," Dr. Staerz explains. "This treatment could help prevent that."

When available, this treatment could be necessary only for several weeks following a transplant. Current anti-rejection drugs must be taken for the transplant recipient's entire life to control organ rejection. The hybrid antibody activity may eventually destroy the T cells that normally attack the transplanted organ, preventing future organ rejection, Dr. Staerz says.

Because a biological "match" must be made between the donor organ and recipient, the odds of a successful organ match are 1 in 100,000. Using a hybrid antibody for treatment, the chance of a successful match may increase to 1 in 4. There were more than 19,000 organ transplants in the United States in 1996, according to the United Network for Organ Sharing.

T cells, known as the body's "killer cells," act as immune-system defenders. Recognized as a foreign object, a transplanted organ is attacked by T cells. In addition, in autoimmune diseases, such as multiple sclerosis, juvenile diabetes and rheumatoid arthritis, T cells attack the body's own cells. The hybrid antibody could be used to help people with these diseases, as well.

For information about National Jewish, call LUNG LINE, (800) 222-LUNG.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "Hybrid Antibody Created At National Jewish Medical And Research Center 'Turns Off' CD4 T Cells Responsible For Organ Transplant Rejection." ScienceDaily. ScienceDaily, 26 February 1998. <www.sciencedaily.com/releases/1998/02/980226001848.htm>.
National Jewish Medical And Research Center. (1998, February 26). Hybrid Antibody Created At National Jewish Medical And Research Center 'Turns Off' CD4 T Cells Responsible For Organ Transplant Rejection. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/1998/02/980226001848.htm
National Jewish Medical And Research Center. "Hybrid Antibody Created At National Jewish Medical And Research Center 'Turns Off' CD4 T Cells Responsible For Organ Transplant Rejection." ScienceDaily. www.sciencedaily.com/releases/1998/02/980226001848.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins